Carl Zeiss Meditec AG

FSX:AFX.DE

57.65 (EUR) • At close November 13, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) EUR.

2023202220212020201920182017201620152014201320122011201020092008200720062005
Revenue 2,089.31,902.8361,646.7851,335.4521,459.3211,280.861,189.8961,088.3651,040.061909.255906.445861.875758.793676.682640.089600.19569.69500
Cost of Revenue 883.535775.238679.572589.935627.437570.471533.163508.819500.378420.882418.624400.511343.957317.955317.799296.754274.176-206.804-171.419
Gross Profit 1,205.7651,127.598967.213745.517831.884710.389656.733579.546539.683488.373487.821461.364414.836358.727322.29303.436295.519206.804171.419
Gross Profit Ratio 0.5770.5930.5870.5580.570.5550.5520.5320.5190.5370.5380.5350.5470.530.5040.5060.51900
Reseach & Development Expenses 349.278291.365232.066218.804173.312159.628145.792123.406111.95799.75197.31993.4584.21572.35663.45561.96259.235-38.303-31.76
General & Administrative Expenses 83.77877.88160.74756.3257.67949.82748.09246.4849.18641.79142.31740.97740.27637.24532.37332.26932.1300
Selling & Marketing Expenses 420.279360.179303.233292.841336.234303.819289.555255.328247.949226.126214.294204.037187.14162.801150.648141.788134.401-74.882-67.86
SG&A 504.057438.06363.98349.161393.913353.646337.647301.808297.135267.917256.611245.014227.416200.046183.021174.057166.531-74.882-67.86
Other Expenses 4.3061.294-2.44700-0.01500000.0172.687-2.57-0.418-16.63312.696-0.49500
Operating Expenses 857.641730.719593.599567.965567.225513.259484.432425.214409.092367.668353.947338.464311.27271.984229.843248.715225.271-113.185-99.62
Operating Income 327.136413.082348.415206.605238.068197.13182.723154.332130.591120.705133.874122.9103.56686.74376.08267.8370.35948.08635.734
Operating Income Ratio 0.1570.2170.2120.1550.1630.1540.1540.1420.1260.1330.1480.1430.1360.1280.1190.1130.12400
Total Other Income Expenses Net 85.42831.471-9.36519.371-34.801-17.94716.255-12.371-28.871-6.16813.025-6.721-2.685-3.7672.5337.525.754-2.5240
Income Before Tax 412.564403.489339.05178.717229.858179.183188.556141.961101.72114.537147.587116.179100.88182.97678.61575.73276.11300
Income Before Tax Ratio 0.1970.2120.2060.1340.1580.140.1580.130.0980.1260.1630.1350.1330.1230.1230.1260.13400
Income Tax Expense 120.555107.578101.53155.29669.27952.95352.77841.99136.15935.3848.46539.78728.60723.3423.51419.49126.46700
Net Income 290.396293.909236.276122.385159.756126.463134.44598.3362.29774.95493.50571.8772.27459.63655.10156.24147.75700
Net Income Ratio 0.1390.1540.1430.0920.1090.0990.1130.090.060.0820.1030.0830.0950.0880.0860.0940.08400
EPS 3.253.292.641.371.791.411.571.210.770.921.130.880.820.680.620.660.6100
EPS Diluted 3.253.292.641.371.791.411.571.210.770.921.130.880.820.680.620.660.6100
EBITDA 502.77482.357409.212266.407285.879212.517214.467165.152133.884134.482167.67136.964127.062107.17698.43594.16994.32559.69646.225
EBITDA Ratio 0.2410.2540.2490.20.1960.1640.1740.1530.130.1490.1910.1630.1670.1620.1580.1570.16600